Abstract
Fluoroquinolone resistance in Staphylococcus aureus results from amino acid substitutions at particular locations in the DNA gyrase A and B subunits as well as in the topoisomerase IV A subunit and from NorA-mediated efflux. More than one resistance mechanism may be present in a single strain. Fluoroquinolone-resistant derivatives of SA-1199, a methicillin-susceptible S. aureus strain, were selected in vivo or in vitro, and their mechanisms of fluoroquinolone resistance were identified. We found that many of the resistance mechanisms described above can develop in derivatives of a single parent strain, either singly or in combination, and can arise in a single step. Variances in MICs for strains with the same apparent resistance mechanisms likely are due to the presence of new or undetected but established means of fluoroquinolone resistance. NorA-mediated resistance can occur in the apparent absence of topoisomerase mutations and in some strains may be the result of a promoter region mutation causing increased expression of norA. However, increased expression of norA can occur independently of this mutation, suggesting that a regulatory locus for this gene exists elsewhere on the chromosome.
MeSH Terms
Anti-Bacterial Agents/pharmacokinetics,pharmacology
Base Sequence
DNA Topoisomerases, Type I/genetics,metabolism
Drug Resistance, Microbial/genetics
Enoxacin/pharmacokinetics
Ethidium/pharmacology
Microbial Sensitivity Tests
Molecular Sequence Data
Mutation
Norfloxacin/pharmacology
Polymorphism, Restriction Fragment Length
Reserpine/pharmacology
Staphylococcus aureus/drug effects,genetics,metabolism
Chemicals
Anti-Bacterial Agents
Enoxacin
Reserpine
DNA Topoisomerases, Type I
Ethidium
Norfloxacin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Kaatz G W
Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan 48201, USA. gkaatz@juno.com
Seo S M
References (23)
23 references, click to expand
-
DNA gyrase subunit stoichiometry and the covalent attachment of subunit A to DNA during DNA cleavage.
Nucleic Acids Res. 1980 Sep 11;8(17):3865-74
PMID: 6255421
-
DNA sequencing with chain-terminating inhibitors.
Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7
PMID: 271968
-
DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcus aureus: close similarity with quinolone resistance mutations in Escherichia coli.
J Bacteriol. 1990 Dec;172(12):7260-2
PMID: 2174869
-
Mechanisms of fluoroquinolone resistance in Staphylococcus aureus.
J Infect Dis. 1991 May;163(5):1080-6
PMID: 1850442
-
Genetic systems in staphylococci.
Methods Enzymol. 1991;204:587-636
PMID: 1658572
-
Detection of gyrA gene mutations associated with ciprofloxacin resistance in methicillin-resistant Staphylococcus aureus: analysis by polymerase chain reaction and automated direct DNA sequencing.
Antimicrob Agents Chemother. 1992 May;36(5):1166-9
PMID: 1510411
-
CI-960, a new fluoroquinolone, for therapy of experimental ciprofloxacin-susceptible and -resistant Staphylococcus aureus endocarditis.
Antimicrob Agents Chemother. 1992 Jun;36(6):1192-7
PMID: 1329613
-
Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter.
Antimicrob Agents Chemother. 1993 Jan;37(1):128-9
PMID: 8431010
-
In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria.
Antimicrob Agents Chemother. 1993 Feb;37(2):366-70
PMID: 8452372
-
Mutants of the Bacillus subtilis multidrug transporter Bmr with altered sensitivity to the antihypertensive alkaloid reserpine.
J Biol Chem. 1993 May 25;268(15):11086-9
PMID: 8098708
-
Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus.
Antimicrob Agents Chemother. 1993 May;37(5):1086-94
PMID: 8517696
-
A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples.
Biotechniques. 1993 Sep;15(3):532-4, 536-7
PMID: 7692896
-
Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome.
Antimicrob Agents Chemother. 1994 Jun;38(6):1345-55
PMID: 8092836
-
Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones.
Mol Microbiol. 1994 Aug;13(4):641-53
PMID: 7997176
-
Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus.
Antimicrob Agents Chemother. 1994 Sep;38(9):2014-23
PMID: 7811012
-
Incidence of various gyrA mutants in 451 Staphylococcus aureus strains isolated in Japan and their susceptibilities to 10 fluoroquinolones.
Antimicrob Agents Chemother. 1995 Jul;39(7):1414-8
PMID: 7492077
-
Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus.
Antimicrob Agents Chemother. 1995 Jul;39(7):1554-8
PMID: 7492103
-
Inducible NorA-mediated multidrug resistance in Staphylococcus aureus.
Antimicrob Agents Chemother. 1995 Dec;39(12):2650-5
PMID: 8592996
-
Alterations in the DNA topoisomerase IV grlA gene responsible for quinolone resistance in Staphylococcus aureus.
Antimicrob Agents Chemother. 1996 May;40(5):1157-63
PMID: 8723458
-
Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus.
Antimicrob Agents Chemother. 1996 Aug;40(8):1881-8
PMID: 8843298
-
Characterization of a mutation in the parE gene that confers fluoroquinolone resistance in Streptococcus pneumoniae.
Antimicrob Agents Chemother. 1997 May;41(5):1166-7
PMID: 9145891
-
Detection of specific sequences among DNA fragments separated by gel electrophoresis.
J Mol Biol. 1975 Nov 5;98(3):503-17
PMID: 1195397
-
Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones.
J Bacteriol. 1990 Dec;172(12):6942-9
PMID: 2174864